Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $167B | +$3B | 244 | 4.26% | Increased |
|
| 2 |
BlackRock
New York
| $152B | -$367M | 265 | 4.47% | Reduced |
|
| 3 |
State Street
Boston,
Massachusetts
| $86.7B | -$1.29B | 251 | 4.89% | Reduced |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $34.7B | +$558M | 285 | 4.51% | Increased |
|
| 5 |
JP Morgan Chase
New York
| $34.2B | -$2.71B | 220 | 4.17% | Reduced |
|
| 6 |
Fidelity Investments
Boston,
Massachusetts
| $31.5B | -$1.82B | 194 | 2.88% | Reduced |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $30.8B | -$494M | 66 | 6.11% | Reduced |
|
| 8 |
Morgan Stanley
New York
| $29.9B | -$676M | 285 | 3.2% | Reduced |
|
| 9 |
Capital World Investors
Los Angeles,
California
| $27.5B | -$282M | 18 | 5.69% | Reduced |
|
| 10 |
Capital International Investors
Los Angeles,
California
| $25.6B | -$654M | 19 | 6.57% | Reduced |
|
| 11 |
Bank of America
Charlotte,
North Carolina
| $23.3B | +$512M | 250 | 2.39% | Increased |
|
| 12 |
T. Rowe Price Associates
Baltimore,
Maryland
| $22.3B | -$372M | 123 | 3.33% | Reduced |
|
| 13 |
Northern Trust
Chicago,
Illinois
| $22.1B | -$78.6M | 232 | 4.38% | Reduced |
|
| 14 |
Norges Bank
Oslo,
Norway
| $19.8B | +$873M | 57 | 4.33% | Increased |
|
| 15 |
Charles Schwab
San Francisco,
California
| $18.6B | +$2.82B | 153 | 5.64% | Increased |
|
| 16 |
Bank of New York Mellon
New York
| $18B | -$1.25B | 170 | 3.95% | Reduced |
|
| 17 |
BBA
Baker Bros. Advisors
New York
| $15.5B | +$171M | 52 | 84.23% | Increased |
|
| 18 |
Capital Research Global Investors
Los Angeles,
California
| $14.8B | +$590M | 15 | 4.23% | Increased |
|
| 19 |
Primecap Management
Pasadena,
California
| $13.4B | +$255M | 17 | 11.69% | Increased |
|
| 20 |
Legal & General Group
London,
United Kingdom
| $13B | +$143M | 124 | 4.67% | Increased |
|
| 21 |
Invesco
Atlanta,
Georgia
| $11.9B | +$118M | 104 | 3.31% | Increased |
|
| 22 |
Dodge & Cox
San Francisco,
California
| $11.8B | +$139M | 12 | 8.02% | Increased |
|
| 23 |
Goldman Sachs
New York
| $11.7B | +$316M | 181 | 2.7% | Increased |
|
| 24 |
Ameriprise
Minneapolis,
Minnesota
| $11.4B | -$105M | 92 | 3.72% | Reduced |
|
| 25 |
Wells Fargo
San Francisco,
California
| $11.3B | +$54M | 271 | 3.25% | Increased |
|